Krystal Biotech (KRYS) Change in Inventory (2023 - 2026)

Krystal Biotech has disclosed Change in Inventory across 4 years of filings, most recently posting $243000.0 for Q1 2026.

• Change in Inventory for Q1 2026 came in at $243000.0, down 82.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (down 53.6% YoY), and the FY2025 annual result was $6.3 million, down 47.21% from the prior year.
• Change in Inventory came in at $243000.0 for Q1 2026 at Krystal Biotech, down from $1.1 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $6.5 million in Q4 2024 to a low of -$880000.0 in Q2 2025.
• The 4-year median for Change in Inventory is $1.2 million (2025), against an average of $1.9 million.
• Peak annual rise in Change in Inventory reached 1225.41% in 2024, while the deepest fall reached 158.5% in 2024.
• Krystal Biotech's Change in Inventory stood at $492000.0 in 2023, then surged by 1225.41% to $6.5 million in 2024, then plunged by 83.78% to $1.1 million in 2025, then sank by 77.03% to $243000.0 in 2026.
• The last three Change in Inventory figures came in at $243000.0 (Q1 2026), $1.1 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.